ViroGates A/S
Research ViroGates A/S (VIRO) on Bullrun: market cap DKK 94.68M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVIRO
- ExchangeCO
- CountryDenmark
- SectorHealthcare
- IndustryMedical Devices
- CurrencyDKK
- Market capDKK 94.68M
- Financial periodQ4 2025
- RevenueDKK 2.36M
- Net income-DKK 2.44M
- Free cash flow-DKK 1.56M
- Gross margin82.4%
Valuation Snapshot
latest market cap is DKK 94.68M.
About ViroGates A/S
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma;
Frequently asked questions
What is ViroGates A/S's market cap?
ViroGates A/S's market capitalization is DKK 94.68M.
What does ViroGates A/S do?
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma;